<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss'><id>tag:blogger.com,1999:blog-868458207806864610</id><updated>2010-01-07T08:37:45.772-05:00</updated><title type='text'>The Pharma Compliance Blog:  Your Space.  For Your Space.</title><subtitle type='html'>The Pharma Compliance Blog is a gathering place in which the GP and Compliance communities can exchange information and discuss issues in a safe and even anonymous environment.</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><link rel='next' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default?start-index=26&amp;max-results=25'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>562</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-2139138328848466792</id><published>2010-01-07T08:30:00.002-05:00</published><updated>2010-01-07T08:37:45.780-05:00</updated><title type='text'>CIS Will Be Exhibiting At DIA's Contemporary Pharmacovigilance And Risk Management Strategies!</title><content type='html'>&lt;strong&gt;&lt;span style="color:#990000;"&gt;When:&lt;/span&gt;&lt;/strong&gt; Monday, January 11th - Wednesday, January 13th&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#990000;"&gt;Where:&lt;/span&gt;&lt;/strong&gt; Renaissance Hotel, Washington, D.C&lt;br /&gt;&lt;br /&gt;For additional conference information, please click &lt;a href="http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=21625&amp;amp;eventType=Meeting"&gt;&lt;span style="color:#990000;"&gt;here.&lt;/span&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-2139138328848466792?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/2139138328848466792/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=2139138328848466792' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/2139138328848466792'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/2139138328848466792'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2010/01/cis-will-be-exhibiting-at-dias.html' title='CIS Will Be Exhibiting At DIA&apos;s Contemporary Pharmacovigilance And Risk Management Strategies!'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-8516399531144213563</id><published>2010-01-07T08:00:00.000-05:00</published><updated>2010-01-07T08:26:31.267-05:00</updated><title type='text'>Senate Rejects Low Cost Imported Drugs</title><content type='html'>By: John Jordan, CIS Senior Compliance Associate&lt;br /&gt;&lt;a href="mailto:johnjordan@cis-partners.com"&gt;johnjordan@cis-partners.com&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Senator Byron Dorgan, D – North Dakota, proposed an amendment that would allow Americans to import low-cost prescriptions from other countries.  This bill was co-sponsored by a number of senators including John McCain, R – Arizona (3).  “Senator Dorgan’s plan would have allowed American pharmacies and drug wholesalers to import federally approved drugs from Canada, Europe, Australia, New Zealand and Japan -- placing them within reach of average consumers (2).”  Many countries have price controls that allow lower prices than what are normally seen in the United States (2).&lt;br /&gt;&lt;br /&gt;Many Democrats were afraid that this amendment would interfere with the agreement that was made with pharmaceutical companies and the government towards the health care bill.  Over the summer the pharmaceutical industry agreed to provide $80 billion in savings towards Americans and the United States government.  According to Robert Pear’s article, “The industry, represented by the Pharmaceutical Research and Manufacturers of America, or PhRMA, adamantly opposes legalizing additional imports and says the government could not guarantee the safety of imported medicines (1).”  &lt;br /&gt;&lt;br /&gt;According to Pear’s article, “the Congressional Budget Office has estimated that the federal government would save over $19.4 billion dollars over the next 10 years (1)” if the amendment had passed.  In addition, Senator Dorgan felt that the amendment could have saved the American consumer four times that amount.  The vote for the amendment came to 51-48 in favor for it.  However, 60 votes were required, under a special rule, in order for it to be passed.  President Obama originally was in favor of the amendment while running for the presidency.  However, many feel that this could interfere with the US Health Care Bill, which is one of the president’s top priorities (2). &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Sources:&lt;br /&gt;(1) &lt;a href="http://www.nytimes.com/2009/12/11/health/policy/11health.html"&gt;&lt;span style="color:#990000;"&gt;http://www.nytimes.com/2009/12/11/health/policy/11health.html&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;(2)&lt;span style="color:#990000;"&gt; &lt;/span&gt;&lt;a href="http://www.drugs.com/news/senate-rejects-plan-import-low-cost-drugs-21524.html"&gt;&lt;span style="color:#990000;"&gt;http://www.drugs.com/news/senate-rejects-plan-import-low-cost-drugs-21524.html&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;(3) &lt;a href="http://www.law360.com/articles/138440"&gt;&lt;span style="color:#990000;"&gt;http://www.law360.com/articles/138440&lt;/span&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-8516399531144213563?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/8516399531144213563/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=8516399531144213563' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/8516399531144213563'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/8516399531144213563'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2010/01/senate-rejects-low-cost-imported-drugs.html' title='Senate Rejects Low Cost Imported Drugs'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-6332385479699582325</id><published>2010-01-06T11:00:00.000-05:00</published><updated>2010-01-06T11:24:24.641-05:00</updated><title type='text'>Send Your Ideas – CIS’ ‘Agency Town Hall Forum’, Full Day Workshop</title><content type='html'>&lt;div align="center"&gt;&lt;strong&gt;IIR’s Government Programs Summit&lt;br /&gt;Monday, February 8th&lt;br /&gt;Baltimore, MD&lt;br /&gt;Hyatt Regency Hotel&lt;/strong&gt;&lt;/div&gt;&lt;br /&gt;By: Chris Cobourn, VP, Regulatory Affairs&lt;br /&gt;&lt;a href="mailto:chriscobourn@cis-partners.com"&gt;chriscobourn@cis-partners.com&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;This will be our 3rd Annual Advanced GP session, with a full day agenda geared towards the experienced GP professional (Monday, February 8th is a pre-conference day, running concurrently to MDRP 101). Our format is an “Agency Town Hall Forum,” where we have the opportunity to discuss topical issues with the agencies across the Medicaid, Medicare, VA and PHS programs. We received great feedback on last year’s conference from the industry participants, as well as the agency representatives, who all enjoyed the opportunity for open dialog.&lt;br /&gt;&lt;br /&gt;At CIS, we work closely with the industry on a variety of GP-related topics, as well as discuss issues directly with the agencies. Prior to last year’s conference we provided many of the topics and issues we have worked with throughout the year in order to facilitate a good discussion, and also to inform the audience of certain topics that could not be discussed at that time. As I said, the result was a very open and comprehensive dialogue from all sides.&lt;br /&gt;&lt;br /&gt;I invite you to participate this year and encourage you to email me any topic ideas in advance. The source of the topic will be confidential, so no company names will be provided. Please email me at &lt;a href="mailto:chriscobourn@cis-partners.com"&gt;chriscobourn@cis-partners.com&lt;/a&gt;.&lt;br /&gt;&lt;br /&gt;We look forward to seeing you in Baltimore in February!&lt;br /&gt;&lt;br /&gt;For additional conference information, please visit the website:&lt;br /&gt;&lt;a href="http://www.iirusa.com/gp/welcome.xml"&gt;http://www.iirusa.com/gp/welcome.xml&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-6332385479699582325?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/6332385479699582325/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=6332385479699582325' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/6332385479699582325'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/6332385479699582325'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2010/01/send-your-ideas-cis-agency-town-hall.html' title='Send Your Ideas – CIS’ ‘Agency Town Hall Forum’, Full Day Workshop'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-1776201125107825955</id><published>2010-01-05T10:30:00.004-05:00</published><updated>2010-01-05T10:45:39.814-05:00</updated><title type='text'>The Adventures of Steven Moore, "Scooter Boy"</title><content type='html'>&lt;div align="left"&gt;By: Steven Moore, CIS Director of Business Development&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;a href="mailto:stevenmoore@cis-partners.com"&gt;stevenmoore@cis-partners.com&lt;/a&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;I thought it would be great to kick off the New Year with a serious article. &lt;/div&gt;&lt;div align="left"&gt;&lt;br /&gt;So my wife and I had grand plans for a house-hopping, crazy holiday --- visiting family and friends and then celebrating New Year’s Eve and heading to Jamaica on January 1st for an eight day trip (mostly because NOBODY wants to hear from the ‘Sales guy’ the first week back from the holidays).&lt;/div&gt;&lt;div align="left"&gt;&lt;br /&gt;As the commercial says, &lt;em&gt;life comes at you fast…&lt;/em&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;br /&gt;On December 15th, with the score tied at 7 in a heated pick-up basketball game to 8, I dove for a loose ball and heard and felt a very loud “POP” in the back of my leg. I went to get up, only to fall down, to try and slug the jerk that kicked me in the back of the leg but, alas, nobody was even within 10 feet of me. Houston, we have a problem. I was no longer 30 going on 18… I was 30 going on 50...&lt;br /&gt;&lt;br /&gt;I limped off the court and got in my car and visions of Jamaica and ‘froo froo’ drinks began to sputter. My mind raced and I called my wife: &lt;/div&gt;&lt;div align="left"&gt;&lt;br /&gt;&lt;/div&gt;&lt;blockquote&gt;&lt;p align="left"&gt;Wifey: “Hello.”&lt;br /&gt;Me: “Um. Yeah. I got hurt. Bad.”&lt;/p&gt;&lt;/blockquote&gt;&lt;div align="left"&gt;These are the calls in life you hate to make and the worries that you don’t have because you can’t predict them. I got home and said, “I think I pulled a muscle --- maybe my calf muscle.” I iced the back of my leg and was in excruciating pain --- but still waited two days and a CIS holiday party to go to the doctor’s office. After a Google search and a “Thompson Test” (which is when you squeeze your calf muscle while lying face down --- and notice that your foot doesn’t move --- try it, it’s creepy), followed by an X-ray, MRI and visit, the dreaded but expected prognosis was given by the orthopedic surgeon: &lt;/div&gt;&lt;blockquote&gt;&lt;p align="left"&gt;“You have fully ruptured your Achilles tendon. It will heal over time (6&lt;br /&gt;months) on its own, but re-rupture is far more likely if you go that&lt;br /&gt;route. Most people who are active and healthy choose surgery. You&lt;br /&gt;will not be able to put any weight on it for 6 weeks post surgery and likely&lt;br /&gt;won’t walk normally for 3 or 4 months.”&lt;/p&gt;&lt;/blockquote&gt;&lt;div align="left"&gt;My holiday Cheerios were officially peed in. &lt;/div&gt;&lt;div align="left"&gt;&lt;br /&gt;Surgery is a scary thing and I don’t have too much pride (heck, that was out the window a long, long time ago) to admit that I was nervous and, well, scared. I didn’t know what to expect or what I was supposed to be afraid of. I chose not to have surgery until 12/28 so that we could still have a semi-normal Christmas celebration and it wouldn’t effect seeing both sides of our families. It was a good move, but at any moment my mind was idle, the devil was at play in his workshop.&lt;/div&gt;&lt;div align="left"&gt;&lt;br /&gt;So I was called back into the surgery and then came the IV, then waiting and then sedatives (I think I recall saying, “Wow, now I know why the Beatles were such good song writers,” to my nurse anesthetist). The last thing I remember is hearing my surgeon say, “This may sting a little.” After that, I woke up and it was all done. I think I was given Propofol, or “Milk of Amnesia”, and I can honestly say it was the wildest experiences to wake up two hours later with ZERO recollection of what occurred. That hasn’t happened since college… Kidding, of course. You guys know I don’t drink. That often.&lt;/div&gt;&lt;div align="left"&gt;&lt;br /&gt;So here’s where the ‘Scooter’ part comes in and what is relevant to the Pharma Compliance Blog. Our industry is sweet and more people need to know about the advances that are happening. First and foremost, somebody sliced open my calf and tied my tendon together without me feeling a thing, and then I awoke to some strong pain but was given medicine to deal with it (I actually only used painkillers for about 48 hours) as well as the appropriate antibiotics to guard against wound infection and, here’s the kicker: I researched my injury and decided to rent a knee walker (which we’ll affectionately call “Scooter”) to replace crutches and it’s been a revelation for me. &lt;/div&gt;&lt;div align="left"&gt;&lt;br /&gt;I can buzz around the house, use the bathroom, take a shower with my leg hanging out and do cool ‘k’ turns with my Scooter without my leg ever touching the ground or being straight up and down as it would be on crutches (and trust me, when the blood flows to the wound, I can feel it!). My uncles and cousins made fun of me and called me ‘Scooter Boy’ during Christmas, but I didn’t care since I’ve read and heard (thanks CIS’ Amy VanDeCar) that those who use the Scooter cut their healing time down and walk sooner. Give me two extra weeks of walking and I’ll take all the derision that comes my way. &lt;/div&gt;&lt;div align="left"&gt;&lt;br /&gt;In fact, when I’m up to it, I plan to take my Scooter to the mall and do ‘laps’ as exercise and cardio while the High School kids make fun of me. Heck, I might even put one of those ‘bicycle bells’ on it and wear a helmet with cool decals. And when I physically return to work in the next week or so, I’ll buzz around the office in my Scooter and will likely be made fun of as well --- but it’s all good! The truth is, when it comes to medicine and healing, we should all take our pride out of the equation and do what’s best for the recovery process. Those suffering with crutches --- and the accompanying worn out armpits and palms --- need only 5 minutes with my Scooter and I can sell them.&lt;/div&gt;&lt;div align="left"&gt;&lt;br /&gt;I’m 8 days post-surgery and am feeling great. Sure, I was SUPPOSED to be in Jamaica right now doing the reggae walk and saying ‘yeah mon’ to every offer from the resort staff (well, almost every offer) --- but life doesn’t work that way. I’ve already learned a lot through this and plan to hold onto it. My New Year’s resolution is to not take so many things for granted, like getting dressed, going to the bathroom, showering, getting a drink, making coffee and, oh yeah, walking and exercise. My wife and caretaker has been a savior and we’re very lucky she is a college professor and home these days!&lt;/div&gt;&lt;div align="left"&gt;&lt;br /&gt;Finally, I send out a big ‘cheers’ to our industry for novel medicines and devices that will help me heal faster than the ancient Greek hero warrior Achilles could himself. I’m convinced that even this great warrior wouldn’t have minded the Romans making fun of him... &lt;/div&gt;&lt;div align="left"&gt;&lt;br /&gt;Achilles, “Scooter Boy”. &lt;/div&gt;&lt;div align="center"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="center"&gt;&lt;/div&gt;&lt;p&gt;&lt;img id="BLOGGER_PHOTO_ID_5423280789286824850" style="DISPLAY: block; MARGIN: 0px auto 10px; WIDTH: 300px; CURSOR: hand; HEIGHT: 400px; TEXT-ALIGN: center" alt="" src="http://2.bp.blogspot.com/_73LHqRgYL4s/S0NdJOKkK5I/AAAAAAAAAaQ/ZZR1QA9qkkY/s400/New+Image.JPG" border="0" /&gt;&lt;/p&gt;&lt;p align="center"&gt;&lt;em&gt;"Gotta dig the holiday beard..."&lt;/em&gt;&lt;/p&gt;&lt;p align="left"&gt;For Your Space and here’s to a Fantastic 2010!&lt;/p&gt;&lt;p align="left"&gt;Steven “Scooter Boy” Moore &lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-1776201125107825955?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/1776201125107825955/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=1776201125107825955' title='4 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/1776201125107825955'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/1776201125107825955'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2010/01/adventures-of-steven-moore-scooter-boy.html' title='The Adventures of Steven Moore, &quot;Scooter Boy&quot;'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://2.bp.blogspot.com/_73LHqRgYL4s/S0NdJOKkK5I/AAAAAAAAAaQ/ZZR1QA9qkkY/s72-c/New+Image.JPG' height='72' width='72'/><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>4</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-8740158619837368490</id><published>2009-12-30T08:30:00.000-05:00</published><updated>2009-12-30T08:30:00.971-05:00</updated><title type='text'>CVS Looks to Generation Health to Head Caremark</title><content type='html'>By: Kerri McCutchin, CIS Compliance Associate&lt;br /&gt;&lt;a href="mailto:kerrimccutchin@cis-partners.com"&gt;kerrimccutchin@cis-partners.com&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;On December 21, 2009, CVS Caremark Corporation announced the appointment of Per G.H. Lofberg as president of its pharmacy benefit management business (PBM), effective January 4, 2010. Lofberg has more than 30 years experience in the healthcare and PBM industry, “including the role of Chairmen for Merck Medco Managed Care LLC, which later became Medco Health Solutions.”(1) Lofberg is currently serving in the roles of President and CEO of Generation Health Inc., a company that focuses on genetic testing benefit management. By hiring Lofberg, Generation Health has become a strategic partner with CVS Caremark; this collaboration has resulted in the expansion of pharmacogenomic (which is the interaction between medications and a patient's genes) clinical and testing services for customers [1].&lt;br /&gt;&lt;br /&gt;One of the services that CVS will offer is counseling patients with certain diseases to undergo genetic tests. Among the first patients to receive counseling are those with diseases in which genes are known to play a role in what drugs are effective in treatment. “The company said those patients will be encouraged to use a drug that has been proven to work on people with a similar genetic profile as their own.” [1]&lt;br /&gt;&lt;br /&gt;It seems many are optimistic about the experience and knowledge Lofberg can bring to CVS Caremark Corporation. Tom Ryan, Chairman, President and CEO of CVS Caremark notes:&lt;br /&gt;&lt;br /&gt;&lt;blockquote&gt;"Per is widely respected in the PBM and health care industry. He brings a wealth&lt;br /&gt;of experience in working with key clients to understand the needs of the&lt;br /&gt;marketplace and produce meaningful results. His expertise, along with his&lt;br /&gt;demonstrated ability to execute growth strategies, makes him the perfect person&lt;br /&gt;to guide our PBM in the evolving health care environment." [1]&lt;/blockquote&gt;One possible explanation for hiring Lofberg might be that it was an initiative taken by CVS Caremark Corporation in hopes of combining its drug benefit management services with patients' genetic profiles. In November, Generation Health Inc. and CVS Caremark Corporation established a partnership to research pharmacogenomics. In particular, pharmacogenomics can determine whether or not a drug works for specific patients [2]. The utilization of pharmacogenomics could improve treatment and reduce costs for Caremark, allowing patients to avoid drugs that would not work for them. CVS will begin to offer some pharmacogenomic services starting in the second quarter of 2010 and will focus largely on diseases such as cancer, heart disease and HIV [3].&lt;br /&gt;&lt;br /&gt;Lofberg  comments that “he is looking forward to the opportunities and challenges of running one of the nation's largest PBMs” and states, "CVS Caremark's corporate resources and its leadership position as the country's largest provider of pharmacy services offers a tremendous platform for innovation and growth in our complex and challenging health care system” [1].&lt;br /&gt;&lt;br /&gt;Sources:&lt;br /&gt;[1] &lt;a href="http://info.cvscaremark.com/newsroom/press-releases/cvs-caremark-appoints-lofberg-president-pbm-business"&gt;http://info.cvscaremark.com/newsroom/press-releases/cvs-caremark-appoints-lofberg-president-pbm-business&lt;/a&gt;&lt;br /&gt;[2] &lt;a href="http://news.yahoo.com/s/ap/20091221/ap_on_bi_ge/us_cvs_caremark_generation_health_2"&gt;http://news.yahoo.com/s/ap/20091221/ap_on_bi_ge/us_cvs_caremark_generation_health_2&lt;/a&gt;&lt;br /&gt;[3] &lt;a href="http://www.google.com/hostednews/ap/article/ALeqM5gN_2fpJwvjczd8KMa40QOOHRLrDgD9CNVN7G0"&gt;http://www.google.com/hostednews/ap/article/ALeqM5gN_2fpJwvjczd8KMa40QOOHRLrDgD9CNVN7G0&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-8740158619837368490?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/8740158619837368490/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=8740158619837368490' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/8740158619837368490'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/8740158619837368490'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/cvs-looks-to-generation-health-to-head.html' title='CVS Looks to Generation Health to Head Caremark'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-8292518863057689742</id><published>2009-12-29T08:30:00.000-05:00</published><updated>2009-12-29T08:30:00.068-05:00</updated><title type='text'>On the Twelfth Day of CIS...</title><content type='html'>&lt;em&gt;As reported to Jess Ebert, CIS Compliance Specialist&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;On the twelfth day of CIS, the blog introduced to me…&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Founding Partner and VP of Account Management, Toni Barsh&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;em&gt;(and Jim Collins, Joe Calarco, Annette Horner, Kimberly Gilbert, Dana Zelig, Beth Kline, Bill Baxter, Jon Dellaquila, Chris Didizian, Venessa Piper-Givler, and Amy VanDeCar)&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What’s your background?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I graduated with a BA and went right into pharma working for a pharmaceutical advertising agency where I held many roles, but became an Account Manager for CME programs and promotional events. I went from one agency to another, helping clients with patient education and working with brand managers on product positioning and marketing. After following the Ad Agency route for a while, I took a job at Wyeth in the Sales and Marketing Department. I helped with the launch of Norplant and worked in company positioning (as Wyeth products expired, we would allocate surplus products to indigent countries for donations).&lt;br /&gt;&lt;br /&gt;Ready for a change, I started a little consulting company in marketing/advertising. I then changed direction and joined a clinical training/education subsidiary of Parexel, where I spent 5 years working as the training manager and transitioning into consulting sales. Due to lack of growth, I started my second business in clinical training and process consulting. After 5 years I teamed up with Jim Collins, and the rest is CIS history!&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: Why did you decide to start CIS?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I ran my second consulting company for 5 years, and was burned out being a "single shingle." [CIS Co-Founder] Jim Collins and I collaborated on a new business venture that immediately interested me. We already had a 10 year working relationship, so partnering with Jim was a no brainer. My best professional decision yet!&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What projects and product lines do you work with at CIS?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I help wherever I am needed. I work primarily in Account Management supporting our managers. I also try to get a bit of Business Development in from time to time.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What do you like about CIS?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I love the culture we have created here and the people I work with. I want and need to learn from the people who surround me, and I think we have some of the most talented employees around….people who want to learn, want to grow and want to be challenged!&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What’s the best holiday gift you’ve ever gotten (or given)?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: The best gift I've ever given was a cruise to Bermuda for my parents' 25th wedding anniversary. The best gift I've ever received was the opportunity to adopt a child and become a parent!&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Email Toni any time at &lt;a href="mailto:tonibarsh@cis-partners.com"&gt;tonibarsh@cis-partners.com&lt;/a&gt;!&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#cc33cc;"&gt;There are 3 days left until the New Year!&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-8292518863057689742?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/8292518863057689742/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=8292518863057689742' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/8292518863057689742'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/8292518863057689742'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/on-twelfth-day-of-cis.html' title='On the Twelfth Day of CIS...'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-6656517578142196288</id><published>2009-12-28T08:30:00.000-05:00</published><updated>2009-12-28T08:30:00.622-05:00</updated><title type='text'>On the Eleventh Day of CIS...</title><content type='html'>&lt;em&gt;As reported to Jess Ebert, CIS Compliance Specialist&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;On the eleventh day of CIS, the blog introduced to me…&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Founding Partner and VP of Operations, Jim Collins&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#ff0000;"&gt;(and Joe Calarco, Annette Horner, Kimberly Gilbert, Dana Zelig, Beth Kline, Bill Baxter, Jon Dellaquila, Chris Didizian, Venessa Piper-Givler, and Amy VanDeCar)&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What’s your background?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I was born in Brooklyn, NY and moved to South Jersey at age 5 when my father, who was a stock broker on Wall Street, took a job with a small start up firm on the Philadelphia Stock Exchange. I went to Rider College and majored in Accounting and Finance. I received my CPA in 1990 and quickly got out of accounting. I worked for Barnett International, a division of PAREXEL Consulting, as VP of Operations for 14 years prior to co-founding CIS in 2004.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: Why did you decide to start CIS?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: After 14 years of a being part of a large public company and spending the majority of my time on internal politics and BS - I thought it would be a refreshing change to build a company where the culture is based on performance, growing professionally and financially, and helping clients.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What company milestones are you proud of?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: Our goal in year 1 was to be in business in year 2, so that is a milestone I am very proud of. Now that we are approaching our 5 year anniversary as a company, I am proud to be working with close to 50 of the smartest, most hard working and talented staff in our industry.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: If you could give your employees once piece of advice, what would it be?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: You get out of your career what you put into it– there are no short cuts. By taking it easy you limit your own growth – professionally and financially.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What’s your favorite holiday movie and why?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: Elf – Buddy is the best!&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What are you most thankful for this holiday season?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: The ability to get up every day and see that I have a healthy family, and I know I have the ability to be in control of my own destiny.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Email Jim any time at &lt;a href="mailto:jimcollins@cis-partners.com"&gt;jimcollins@cis-partners.com&lt;/a&gt;!&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#993399;"&gt;&lt;strong&gt;There are 4 days until the New Year!&lt;/strong&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-6656517578142196288?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/6656517578142196288/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=6656517578142196288' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/6656517578142196288'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/6656517578142196288'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/on-eleventh-day-of-cis.html' title='On the Eleventh Day of CIS...'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-9210655437960990733</id><published>2009-12-23T09:30:00.000-05:00</published><updated>2009-12-23T09:38:42.331-05:00</updated><title type='text'>On the Tenth Day of CIS...</title><content type='html'>&lt;em&gt;As reported to Jess Ebert, CIS Compliance Specialist&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;On the tenth day of CIS, the blog introduced to me…&lt;br /&gt;Senior Compliance Manager, Joseph Calarco&lt;/strong&gt;&lt;br /&gt;&lt;em&gt;(and Annette Horner, Kimberly Gilbert, Dana Zelig, Beth Kline, Bill Baxter, Jon Dellaquila, Chris Didizian, Venessa Piper-Givler, and Amy VanDeCar)&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What’s your background?&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;span style="color:#009900;"&gt;A: I started my career at the University of Pennsylvania’s Treatment Research Center as a site coordinator supporting clinical trials on anabolic steroid use and alcohol dependence.  &amp;shy;&amp;shy;&amp;shy;After a short stint as a Data Coordinator at Scirex (small CRO), I entered a full-time Clinical Social Work Graduate Program at Bryn Mawr College.  I worked part-time at Aventis Behring during Social Work school and worked there for two years full-time after graduating with my M.S. in Social Services. &lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;In 2002, I joined Merck &amp;amp; Co, Inc. as a project leader in Global Clinical Data Operations.  In this role I led Clinical Data Management teams that filed Infectious Disease and Oncology products.  For more than four years I worked as a manager responsible for the External Data Services and Clinical Pharmacology departments.  As a manager, I was responsible for managing Merck’s book of business and the staff resourced to support the projects in these departments.  Additionally, I was charged with several process improvement projects, one of which allowed me to complete my Six Sigma Green Belt certification.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What projects and product lines do you work with at CIS?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: My primary project at CIS has been the Shire Standard Operating Procedures project.  I am thankful for the opportunity to learn a lot about R&amp;amp;D and Commercial Compliance concerns in a short period of time. &lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What do you like about CIS?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: The people I get to work with and the company’s size. Team chemistry can be elusive at most jobs.  I am fortunate that the people I interact with each day are open, knowledgeable and lead by example.  More importantly, they play as hard as they work.  Anyone who has been in any industry long enough knows that situations like this are the exception and not the norm.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;CIS’ size also means there are an abundance of opportunities to contribute to and succeed.  Large corporations often struggle to make employees feel like their contributions matter.&lt;/span&gt; &lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What are you most thankful for this holiday season?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: My family’s good health and my friends.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What is your favorite holiday cookie or food?&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span style="color:#009900;"&gt;A: My mother-in-law’s French Toast Casserole.  It is basically French Toast covered maple syrup and brown sugar.  How can you go wrong?&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What is your favorite holiday song?&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;span style="color:#009900;"&gt;A: I have two favourite holiday songs. The U2 version of “Christmas (Baby Please Come Home)” and The Bare Naked Ladies version of “Auld Lang Syne”.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Email Joe any time at &lt;a href="mailto:joecalarco@cis-partners.com"&gt;joecalarco@cis-partners.com&lt;/a&gt;!&lt;br /&gt;&lt;br /&gt;Currently there are:&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;2 days until Christmas,&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;and 3 days until Kwanzaa!&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#cc33cc;"&gt;The days are getting longer!&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-9210655437960990733?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/9210655437960990733/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=9210655437960990733' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/9210655437960990733'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/9210655437960990733'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/on-tenth-day-of-cis.html' title='On the Tenth Day of CIS...'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-592902620620558134</id><published>2009-12-23T08:30:00.000-05:00</published><updated>2009-12-23T08:33:34.645-05:00</updated><title type='text'>Articles of the Week!</title><content type='html'>Courtesy of: Kerri McCutchin, CIS Compliance Associate&lt;br /&gt;&lt;a href="mailto:kerrimccutchin@cis-partners.com"&gt;kerrimccutchin@cis-partners.com&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;1) Senate moves health bill forward&lt;br /&gt;&lt;a href="http://www.cnn.com/2009/POLITICS/12/22/health.care.senate.vote/index.html"&gt;http://www.cnn.com/2009/POLITICS/12/22/health.care.senate.vote/index.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;2) Obesity, Inactivity Keeping Heart Health Stats Down&lt;br /&gt;&lt;a href="http://news.yahoo.com/s/hsn/20091218/hl_hsn/obesityinactivitykeepinghearthealthstatsdown"&gt;http://news.yahoo.com/s/hsn/20091218/hl_hsn/obesityinactivitykeepinghearthealthstatsdown&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;3) Drug Maker Sanofi-Aventis Buys Chattem for $1.9 Billion&lt;br /&gt;&lt;a href="http://www.nytimes.com/2009/12/22/business/global/22drug.html?_r=1&amp;amp;adxnnl=1&amp;amp;ref=health&amp;amp;adxnnlx=1261497699-LLjRGlc6Be/Ntgc/K0065w"&gt;http://www.nytimes.com/2009/12/22/business/global/22drug.html?_r=1&amp;amp;adxnnl=1&amp;amp;ref=health&amp;amp;adxnnlx=1261497699-LLjRGlc6Be/Ntgc/K0065w&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;4) Cosmetic Surgeons Get Reid to Tax Tanning Salons Instead&lt;br /&gt;&lt;a href="http://online.wsj.com/article/SB126144830913601141.html"&gt;http://online.wsj.com/article/SB126144830913601141.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;5) COBRA Help For Laid-Off Workers May Come Before Christmas&lt;br /&gt;&lt;a href="http://www.kaiserhealthnews.org/Stories/2009/December/17/cobra-extension.aspx"&gt;http://www.kaiserhealthnews.org/Stories/2009/December/17/cobra-extension.aspx&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-592902620620558134?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/592902620620558134/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=592902620620558134' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/592902620620558134'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/592902620620558134'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/articles-of-week_23.html' title='Articles of the Week!'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-5385343239407784126</id><published>2009-12-22T11:00:00.002-05:00</published><updated>2009-12-22T11:24:12.331-05:00</updated><title type='text'>All I Want For Christmas Is….Healthcare Reform?</title><content type='html'>By: Jordan Mummau, CIS Compliance Associate&lt;br /&gt;&lt;a href="mailto:jordanmummau@cis-partners.com"&gt;jordanmummau@cis-partners.com&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;One giant leap for lawmakers, an even bigger leap for healthcare. In the waning hours of Sunday night, and into 1:00am Monday morning on December 21st, the U.S. Senate voted to end debate on the health reform bill. This vote will propel the legislation to a final vote on Christmas Eve. &lt;a title="" style="mso-footnote-id: ftn1" href="http://www.blogger.com/post-create.g?blogID=868458207806864610#_ftn1" name="_ftnref1"&gt;[1]&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;If this bill is passed and aligned with the one passed by the House of Representatives, 30 million uninsured Americans will be opening the gift of insurance this Christmas. However, some Republicans may argue that this bill is no gift at all, but rather will prove to be a detrimental and counterproductive mistake. Arizona Senator John McCain was quoted as saying “We must look back and say, we did everything we can to prevent this terrible mistake from taking place”.&lt;a title="" style="mso-footnote-id: ftn2" href="http://www.blogger.com/post-create.g?blogID=868458207806864610#_ftn2" name="_ftnref2"&gt;[1]&lt;/a&gt; As you may have guessed, both the Democratic and Republican parties tended to support party norms on this vote, with all 58 Democrats, and the Senate’s two Independents, voting in favor of the bill against unanimous Republican opposition. The vote, 60-40, was considered by both sides to be monumental.&lt;br /&gt;&lt;br /&gt;The actual legislation aims at providing health benefits to more than 30 million people who are currently uninsured. The bill would require all Americans to pay financial penalties for failing to obtain health insurance and would provide federal subsidies to help moderate- to low-income families buy private coverage.&lt;a title="" style="mso-footnote-id: ftn3" href="http://www.blogger.com/post-create.g?blogID=868458207806864610#_ftn3" name="_ftnref3"&gt;[2]&lt;/a&gt; These services would be made possible by the highly criticized complex array of taxes that would yield a tax hike for individuals earning more than $200,000 and couples earning more than $250,000.&lt;a title="" style="mso-footnote-id: ftn4" href="http://www.blogger.com/post-create.g?blogID=868458207806864610#_ftn4" name="_ftnref4"&gt;[3]&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Supporters of the Bill claim that its $871 billion price tag will actually assist the U.S. Government in reducing the federal budget deficit by $132 billion through new revenues and cuts in spending. However, Republicans are more apprehensive about the severe expense of the bill, charging Democrats with recklessly rushing to adopt the proposed 2,700 page bill that would reshape one sixth (1/6) of the nation’s economy.&lt;a title="" style="mso-footnote-id: ftn5" href="http://www.blogger.com/post-create.g?blogID=868458207806864610#_ftn5" name="_ftnref5"&gt;[4]&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Inherent in all reforms are potential benefits and risks, and this legislation is without exception. While it may be difficult for one party to see the other’s point of view, it is certainly easy for both parties to recognize the sheer magnitude of this decision. As citizens of this country, we can only hope that the people we have elected to make these decisions do so in a way that will allow this great nation to prosper. Happy Holidays and God Bless America!&lt;br /&gt;&lt;br /&gt;Sources:&lt;br /&gt;[1]&lt;a href="http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20091221/health_overhaul_091221/20091221?hub="&gt; http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20091221/health_overhaul_091221/20091221?hub=&lt;/a&gt;&lt;br /&gt;&lt;a title="" style="mso-footnote-id: ftn3" href="http://www.blogger.com/post-create.g?blogID=868458207806864610#_ftnref3" name="_ftn3"&gt;[2]&lt;/a&gt; &lt;a href="http://www.nytimes.com/2009/12/21/us/21vote.html?pagewanted=1&amp;amp;_r=1&amp;amp;hp"&gt;http://www.nytimes.com/2009/12/21/us/21vote.html?pagewanted=1&amp;amp;_r=1&amp;amp;hp&lt;/a&gt;&lt;br /&gt;&lt;a title="" style="mso-footnote-id: ftn4" href="http://www.blogger.com/post-create.g?blogID=868458207806864610#_ftnref4" name="_ftn4"&gt;[3]&lt;/a&gt; &lt;a href="http://www.thaindian.com/newsportal/health1/senate-passes-health-care-reform-bill-in-cloture-vote_100292777.html"&gt;http://www.thaindian.com/newsportal/health1/senate-passes-health-care-reform-bill-in-cloture-vote_100292777.html&lt;/a&gt;&lt;br /&gt;&lt;a title="" style="mso-footnote-id: ftn5" href="http://www.blogger.com/post-create.g?blogID=868458207806864610#_ftnref5" name="_ftn5"&gt;[4]&lt;/a&gt; &lt;a href="http://www.nytimes.com/2009/12/21/us/21vote.html?pagewanted=1&amp;amp;_r=1&amp;amp;hp"&gt;http://www.nytimes.com/2009/12/21/us/21vote.html?pagewanted=1&amp;amp;_r=1&amp;amp;hp&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-5385343239407784126?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/5385343239407784126/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=5385343239407784126' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/5385343239407784126'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/5385343239407784126'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/all-i-want-for-christmas-ishealthcare.html' title='All I Want For Christmas Is….Healthcare Reform?'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-1313440517863867886</id><published>2009-12-22T08:30:00.001-05:00</published><updated>2009-12-22T08:30:01.380-05:00</updated><title type='text'>On the Ninth Day of CIS...</title><content type='html'>&lt;em&gt;As reported to Jess Ebert, CIS Compliance Specialist&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;On the ninth day of CIS, the blog introduced to me…&lt;br /&gt;CIS Senior Director, Clinical Consulting Services, Annette Horner &lt;/strong&gt;&lt;br /&gt;&lt;em&gt;(and Kimberly Gilbert, Dana Zelig, Beth Kline, Bill Baxter, Jon Dellaquila, Chris Didizian, Venessa Piper-Givler, and Amy VanDeCar)&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What’s your background?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: For the past 15 years, I’ve worked as a consultant to global pharmaceutical and medical device companies to develop and implement clinical and regulatory processes resulting from large-scale clinical/regulatory re-engineering or compliance risk mitigation projects.  For five years before that, my consulting work focused on developing clinical and regulatory training programs for a variety of pharmaceutical clinical research clients.  Earlier in my professional life I taught literature and writing in high schools and colleges.  When I decided I wanted to understand more about how organizations work, I pursued a PhD at Temple University in Organizational Design, thinking I would work in a college or university setting.   By the time I finished the PhD work, I had a network of business consulting friends and entered the world of pharmaceutical consulting in that way.&lt;/span&gt; &lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What projects and product lines do you work with at CIS?&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span style="color:#009900;"&gt;A: I work on clinical compliance client projects.   I’m involved in client meetings and in developing client proposals for clinical compliance services.  I also work on the upfront design and planning for a new client project, and provide direct client service on SOP projects that involve creating a compliance framework.  I also designed and helped implement the Clinical PCX.  &lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What do you like about CIS?&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span style="color:#009900;"&gt;A: I had worked in another company with the CIS owners, so I was first attracted to CIS by that prior experience with the owners, both of whom I admire for their business acumen and ethics, as well as their emphasis on transferring authority to others in the company.  I also like the CIS business model, especially the clear focus on providing compliance services across a single complex industry,  and the fact that CIS is still strongly an entrepreneurial company which means it will attract capable and flexible staff who want to grow with the company.  That’s good for CIS and for clients as well.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What are you looking forward to this holiday season?&lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#009900;"&gt;A: This has been a year of transition for me.  My husband and I moved from Ohio to North Carolina last February.  Now we are much closer to family and long-time friends,  so I’m looking forward to spending time with my special people and maybe doing a little wintertime gardening.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Email Annette any time at &lt;a href="mailto:annettehorner@cis-partners.com"&gt;annettehorner@cis-partners.com&lt;/a&gt;!&lt;br /&gt;&lt;br /&gt;Currently there are:&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;3 days until Christmas,&lt;/span&gt; &lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;and 4 days until Kwanzaa!&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#cc33cc;"&gt;The days are getting longer!&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-1313440517863867886?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/1313440517863867886/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=1313440517863867886' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/1313440517863867886'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/1313440517863867886'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/on-ninth-day-of-cis.html' title='On the Ninth Day of CIS...'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-6097813038767381166</id><published>2009-12-22T08:30:00.000-05:00</published><updated>2009-12-22T08:30:00.302-05:00</updated><title type='text'>On the Eighth Day of CIS...</title><content type='html'>&lt;em&gt;As reported to Jess Ebert, Compliance Specialist&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;On the eighth day of CIS, the blog introduced to me…&lt;br /&gt;Compliance Manager, Kimberly Gilbert&lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#ff0000;"&gt;&lt;em&gt;(and Dana Zelig, Beth Kline, Bill Baxter, Jon Dellaquila, Chris Didizian, Venessa Piper-Givler, and Amy VanDeCar)&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;&lt;strong&gt;Q: What’s your background?&lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#009900;"&gt;A: I am a registered nurse with eleven years of clinical research experience in various capacities across the pharmaceutical industry including roles at the sponsor level, the investigative site, and contract research organizations (CROs). Most of my previous experience in the clinical research arena consists of managing clinical trials across all phases of the drug development cycle in a clinical role.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What projects and product lines do you work with at CIS?&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span style="color:#009900;"&gt;A: I currently work on the clinical product lines at CIS.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: Why did you decide to join CIS?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I decided to join CIS for two reasons; I wanted to work for a company where I felt valued as an employee and I was also looking  for variety in my career. I have found both of these qualities at CIS. I finally feel like I am part of an organization where my ideas and opinions are valued as well as appreciated, and for that I am truly thankful. I also feel like variety is the spice of life, and here at CIS I never have the same day twice! I am able to utilize my previous experience in the pharmaceutical industry in so many different directions at CIS and that makes for interesting days!&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What are you looking forward to this holiday season?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: Having some time off to relax and enjoy the wonders of the season with family and friends! OH and PRESENTS!&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Email Kimberly any time at &lt;a href="mailto:kimgilbert@cis-partners.com"&gt;kimberlygilbert@cis-partners.com&lt;/a&gt;!&lt;br /&gt;&lt;br /&gt;Currently there are:&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;3 days until Christmas,&lt;/span&gt; &lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;and 4 days until Kwanzaa!&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#cc33cc;"&gt;The days are now getting longer!&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-6097813038767381166?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/6097813038767381166/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=6097813038767381166' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/6097813038767381166'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/6097813038767381166'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/on-eighth-day-of-cis.html' title='On the Eighth Day of CIS...'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-758804198696909338</id><published>2009-12-21T08:30:00.001-05:00</published><updated>2009-12-21T08:30:01.468-05:00</updated><title type='text'>On the Seventh Day of CIS...</title><content type='html'>&lt;em&gt;As reported to Jess Ebert, Compliance Specialist&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;On the seventh day of CIS, the blog introduced to me…&lt;br /&gt;PCX Product Manager, Dana Zelig&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#ff0000;"&gt;(and Beth Kline, Bill Baxter, Jon Dellaquila, Chris Didizian, Venessa Piper-Givler, and Amy VanDeCar)&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What’s your background?&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;span style="color:#009900;"&gt;A: Prior to joining CIS, I worked in Regulatory Affairs at a large pharma company, and in the Internal Audit department of a large bank. Both positions provided me with an appreciation of compliance that has served me well at CIS.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What projects and product lines do you work with at CIS?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I am the PCX Product Manager the and co-editor of the Pharma Compliance Blog, which are great products, and great tools to stay up to date on regulations and current events in the pharma space. I also work with CIS’ GP SMEs performing audits, assessments, and calculations.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: Why did you decide to join CIS?&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span style="color:#009900;"&gt;A: I decided to join CIS because it seemed totally different than the companies I came from. It is a company where hard work and a good attitude are always appreciated, which makes it a great place to be every day (or at least the days I’m not visiting clients).&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What’s the best gift you ever gave someone for the holidays?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: What’s the best gift you ever received for the holidays? One year my grandmother took my whole family on a cruise for Christmas. That was definitely the best Christmas ever. We didn’t get each other big presents that year, but my brother and sister and I brought stockings for each other and filled them with crazy gifts. I got a pair of Santa boxers that I still wear all the time.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What is your favorite holiday song?&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;span style="color:#009900;"&gt;A: I love Oh Holy Night. It always puts me in the holiday spirit!&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Email Dana any time at &lt;a href="mailto:danazelig@cis-partners.com"&gt;danazelig@cis-partners.com&lt;/a&gt;!&lt;br /&gt;&lt;br /&gt;Currently there are:&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;4 days until Christmas,&lt;/span&gt; &lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;and 5 days until Kwanzaa!&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#cc33cc;"&gt;&lt;strong&gt;Today is Winter Solstice!&lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-758804198696909338?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/758804198696909338/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=758804198696909338' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/758804198696909338'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/758804198696909338'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/on-seventh-day-of-cis.html' title='On the Seventh Day of CIS...'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-2439321900930528028</id><published>2009-12-18T08:30:00.001-05:00</published><updated>2009-12-18T08:30:00.228-05:00</updated><title type='text'>On the Sixth Day of CIS...</title><content type='html'>&lt;em&gt;As reported to Jess Ebert, Compliance Specialist&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;On the sixth day of CIS, the blog introduced to me…&lt;br /&gt;Compliance Manager, Beth Kline&lt;/strong&gt;&lt;br /&gt;(and Bill Baxter, Jon Dellaquila, Chris Didizian, Venessa Piper-Givler, and Amy VanDeCar)&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Q:  What’s your background?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A:  I have a BA in Organizational Management and a MA in Teaching.  I have worked in pharmaceutical consulting for over 12 years and taught English in China for two years.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What projects and product lines do you work with at CIS?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I work in clinical and manufacturing.  I am also the subject matter expert for the Clinical PCX.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What do you like about CIS?&lt;/span&gt;&lt;/strong&gt; &lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I like that it is a small company where you can be actively involved in all aspects of the business.  I like the variety of work they do and never knowing what tomorrow might bring!&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: Why did you decide to join CIS?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A:  I wanted to get back into consulting and joining CIS provided that opportunity.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What CIS accomplishments are you most proud of this year?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A:  Hiring me?  HAHA!  Kidding – expanding into manufacturing and all of that business they are acquiring…excellent!&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What are you looking forward to this holiday season?&lt;/strong&gt;&lt;/span&gt; &lt;br /&gt;&lt;span style="color:#009900;"&gt;A: Having almost two weeks off.  Living in New York and driving six hours roundtrip every weekend to and from home has been a bit tough on my family life, so having some extended time at home will be very welcome at this time of year.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What’s your favorite holiday movie?&lt;/span&gt;&lt;/strong&gt; &lt;br /&gt;&lt;span style="color:#009900;"&gt;A: My favorite holiday movie is White Christmas.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What's your favorite holiday tradition?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A:  Eating cookies!&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What are you most thankful for this holiday season?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: My job and an understanding and patient husband.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What is your favorite holiday cookie or food?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I love them all!!!&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What is your favorite holiday song?&lt;/span&gt;&lt;/strong&gt; &lt;br /&gt;&lt;span style="color:#009900;"&gt;A: Joy to the World&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Email Beth any time at &lt;a href="mailto:bethkline@cis-partners.com"&gt;bethkline@cis-partners.com&lt;/a&gt;!&lt;br /&gt;&lt;br /&gt;Currently there are:&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;7 days until Christmas,&lt;/span&gt; &lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;8 days until Kwanzaa,&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#cc33cc;"&gt;and 3 days until Winter Solstice!&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000099;"&gt;Tonight is the 8th night of Chanukah!&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-2439321900930528028?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/2439321900930528028/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=2439321900930528028' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/2439321900930528028'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/2439321900930528028'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/on-sixth-day-of-cis.html' title='On the Sixth Day of CIS...'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-5358787441486595226</id><published>2009-12-18T08:00:00.001-05:00</published><updated>2009-12-18T10:24:41.813-05:00</updated><title type='text'>Articles of the Week!</title><content type='html'>Courtesy of: Jess Ebert, CIS Compliance Specialist&lt;br /&gt;&lt;a href="mailto:jessicaebert@cis-partners.com"&gt;jessicaebert@cis-partners.com&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;1) Amendment To Allow Drug Importation Fails In Senate&lt;br /&gt;&lt;a href="http://www.medicalnewstoday.com/articles/174295.php"&gt;&lt;span style="color:#cc0000;"&gt;http://www.medicalnewstoday.com/articles/174295.php&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;2) Pharma Faces More Scrutiny On Drug Prices&lt;br /&gt;&lt;a href="http://www.fiercepharma.com/story/pharma-faces-scrutiny-drug-prices/2009-12-08"&gt;&lt;span style="color:#cc0000;"&gt;http://www.fiercepharma.com/story/pharma-faces-scrutiny-drug-prices/2009-12-08&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;3) Senators: Drug Makers Will Pay More For Health Bill&lt;br /&gt;&lt;a href="http://www.drugs.com/news/senators-makers-pay-more-health-bill-21563.html"&gt;&lt;span style="color:#cc0000;"&gt;http://www.drugs.com/news/senators-makers-pay-more-health-bill-21563.html&lt;/span&gt;&lt;/a&gt;&lt;span style="color:#cc0000;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;4) Democrats Drop Plan to Expand Medicare&lt;br /&gt;&lt;a href="http://online.wsj.com/article/SB126083637029991305.html"&gt;&lt;span style="color:#cc0000;"&gt;http://online.wsj.com/article/SB126083637029991305.html&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;5) WHO Wants Health Issues at Heart of Climate Talks&lt;br /&gt;&lt;a href="http://www.cnn.com/2009/HEALTH/12/17/climate.change.health/index.html"&gt;&lt;span style="color:#cc0000;"&gt;http://www.cnn.com/2009/HEALTH/12/17/climate.change.health/index.html&lt;/span&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-5358787441486595226?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/5358787441486595226/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=5358787441486595226' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/5358787441486595226'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/5358787441486595226'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/articles-of-week_18.html' title='Articles of the Week!'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-6708590463352637417</id><published>2009-12-17T08:30:00.000-05:00</published><updated>2009-12-17T08:30:01.345-05:00</updated><title type='text'>On the Fifth Day of CIS...</title><content type='html'>&lt;em&gt;As reported to Jess Ebert, Compliance Specialist&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;On the fifth day of CIS, the blog introduced to me…&lt;br /&gt;CIS Strategic Advisor, Government Affairs, Bill Baxter&lt;/strong&gt;&lt;br /&gt;(and Jon Dellaquila, Chris Didizian, Venessa Piper-Givler, and Amy VanDeCar)&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Q: What’s your background?&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;span style="color:#009900;"&gt;A: I directed the Medicaid &amp;amp; State Rebate Programs for all the J&amp;amp;J operating companies for over 10 years. Prior to that I taught school for a couple of years before joining J&amp;amp;J as a sale rep, moving into sales training &amp;amp; management, and ultimately into government affairs.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What projects and product lines do you work with at CIS?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: My main focus is GP, working with Chris Cobourn, Clarissa Crain, Steven Moore and Sabrina Skari. My main product line would be the Pharma Compliance Exchange (PCX) and providing compliance guidance to various operating companies.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What do you like about CIS?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#33cc00;"&gt;A: The professionalism as well as the feel of a “small” (but successful and rapidly growing) company environment.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: Why did you decide to join CIS?&lt;/strong&gt;&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#009900;"&gt;A:  I liked the enthusiasm, talent and quality of the individuals here at CIS (AND, my wife was willing to pay Jim &amp;amp; Toni to hire me… )&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What CIS accomplishments are you most proud of this year?&lt;/strong&gt;&lt;/span&gt; &lt;br /&gt;&lt;span style="color:#009900;"&gt;A: As a member of the company, making the “100” listing. As an individual, I’m proud of obtaining access to a number of companies.&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;&lt;br /&gt;Q: What are you looking forward to this holiday season?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: Spending time with our “boys”, singing the “Halleluiah Chorus” with the choir at Christmas services, and getting “Christmas Letters” from friends and family (and at the same time guessing what news is true and what are “stretched” family facts…)&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;&lt;br /&gt;Q: What’s your favorite holiday movie?&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;span style="color:#009900;"&gt;A: “Die Hard” (it takes place at Christmas doesn’t it?), and “A Christmas Story” (I always wanted a BB gun…)&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What's your favorite holiday tradition?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: Opening presents on Christmas morning and watching the boys’ expressions. (I was frequently tempted to put the proverbial lumps of coal in their stockings…)&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What’s the best gift you ever gave someone for the holidays?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: A cruise (but she had to take it with me…)&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What’s the best gift you ever received for the holidays?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: Getting to go on the cruise I just mentioned.&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;&lt;br /&gt;Q: What are you most thankful for this holiday season?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A:  That the family is safe, sound and healthy, and that the economy did not collapse as feared.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What is your favorite holiday cookie or food?&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;span style="color:#009900;"&gt;A:  Macadamia nut cookies and Christmas ham; does a nice Merlot count as holiday “food”?&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What is your favorite holiday song?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I have several, but if I have to pick one it’s probably “There’s no place like home for the holidays.”&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Email Bill any time at &lt;a href="mailto:billbaxter@cis-partners.com"&gt;billbaxter@cis-partners.com&lt;/a&gt;!&lt;br /&gt;&lt;br /&gt;Currently there are:&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;8 days until Christmas,&lt;/span&gt; &lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;9 days until Kwanzaa,&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#cc33cc;"&gt;and 4 days until Winter Solstice!&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000099;"&gt;Tonight is the 7th night of Chanukah!&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-6708590463352637417?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/6708590463352637417/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=6708590463352637417' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/6708590463352637417'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/6708590463352637417'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/on-fifth-day-of-cis.html' title='On the Fifth Day of CIS...'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-5307360322866533711</id><published>2009-12-16T10:00:00.002-05:00</published><updated>2009-12-16T10:37:13.927-05:00</updated><title type='text'>Surprise Tricare Ruling Handed Down</title><content type='html'>By: Dave Rice, CIS Director of Federal Contracting&lt;br /&gt;&lt;a href="mailto:daverice@cis-partners.com"&gt;daverice@cis-partners.com&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;As many of you may have heard, the United States District Court for the District of Columbia recently ruled on the Tricare Retail Pharmacy Program (TRRx) issue in a decision that surprised many, including myself. Below is some basic background information on the issue as well as analysis of the ruling that was provided to us by Joy Sturm, Partner, &lt;a href="http://www.hhlaw.com/home/"&gt;&lt;span style="color:#cc0000;"&gt;Hogan &amp;amp; Hartson LLP&lt;/span&gt;&lt;/a&gt;.&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Background&lt;br /&gt;&lt;/strong&gt;On January 28, 2008, Congress enacted the National Defense Authorization Act for Fiscal Year 2008 ("NDAA-08"). Section 703 of NDAA-08 requires that pharmaceuticals paid for by the Department of Defense ("Department" or "DoD") under its TRICARE retail pharmacy program be subject to pricing standards known as Federal Ceiling Prices. The Department promulgated a final rule implementing section 703 on March 17, 2009. Under this rule, pharmaceutical manufacturers cannot receive more than the Federal Ceiling Prices for pharmaceuticals purchased by DoD for the retail pharmacy program, and must refund amounts in excess of the Federal Ceiling Prices for prescriptions filled on or after January 28, 2008. The Coalition for Common Sense in Government Procurement ("Coalition") challenged the Department's rule, asserted that the rule should be set aside because, inter alia, the Department erroneously interpreted NDAA-08 to require refunds by manufacturers to DoD and to require the statute's obligations to apply beginning on January 28, 2008.&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Analysis of Ruling&lt;br /&gt;&lt;/strong&gt;&lt;a name="OLE_LINK2"&gt;&lt;/a&gt;&lt;a name="OLE_LINK1"&gt;In a surprising decision, on December 7 the U.S. District Court for the District of Columbia ruled that while the Department of Defense (DoD) did not follow proper procedures in issuing its Tricare Retail Pharmacy (TRRx) Final Rule (74 Fed. Reg. 11,279 (Mar. 17, 2009)) implementing Section 703 of the National Defense Authorization Act for FY 2008, the statute "requires that Federal Ceiling Prices apply to all retail pharmacy program prescriptions filled on or after January 28, 2008." &lt;/a&gt;&lt;br /&gt;&lt;br /&gt;While the court found for the Coalition on its procedural challenge to the Final Rule, it sided with DoD on the substantive issue presented in the case. The court held that because Section 703 did not mandate a rebate program, DoD had been required to exercise its discretion in requiring rebates from manufacturers under its Final Rule. The court therefore concluded that DoD's statements throughout the Final Rule that such a program was required "by operation of law" by Section 703 rendered the Final Rule procedurally defective.&lt;br /&gt;&lt;br /&gt;The court held that remand of the Final Rule was necessary so that the agency could exercise its discretion in implementing the statute. However, the court was clear that DoD could, in exercising its discretion, reissue a rule with the same substantive requirements. In view of this conclusion, the court decided not to vacate the TRRx Final Rule, thereby leaving the voluntary agreement program in place.&lt;br /&gt;&lt;br /&gt;&lt;u&gt;In addressing the substantive issue presented, the court agreed with DoD that the statute entitles DoD to FCP-based pricing as of January 28, 2008.&lt;/u&gt; The court rejected the Coalition's argument that the Final Rule was impermissibly retroactive, holding instead that "[i]t is the statute, not the rule, which made transactions on or after January 28, 2008, subject to Federal Ceiling Prices . . . ." The court did not analyze how a rebate could be applied absent a contractual agreement by the manufacturer.&lt;br /&gt;&lt;br /&gt;Accordingly, pending DoD's consideration on remand, the Final Rule remains in place as do TRRx voluntary rebate agreements. DoD is required to report to the court by March 1, 2010 on its reconsideration of the Final Rule.&lt;br /&gt;&lt;br /&gt;It is likely that DoD will now turn its attention to outstanding rebate amounts for quarters pre-dating the voluntary agreements.&lt;br /&gt;&lt;br /&gt;Whether this decision will have any impact on Non-FAMP and AMP remains to be seen. The VA has not yet stated whether this decision will impact its earlier guidance to manufacturers to identify and exclude TRRx utilization from Non-FAMP as Federal sales.&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;If you have any questions regarding this new TRRx development or surrounding the program generally, please contact Joy Sturm at (301) 294-5995 or at &lt;a href="mailto:jesturm@hhlaw.com"&gt;jesturm@hhlaw.com&lt;/a&gt;. &lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;For the 11/30/09 Memorandum Opinion please see the following link:&lt;/strong&gt; &lt;a href="http://www.fdalawblog.net/files/mem.-op.-the-coalition-for-common-sense-.-.-.-v.-u.s.-08-cv-996-d.d.c.-nov.-30-209-2.pdf"&gt;&lt;span style="color:#cc0000;"&gt;http://www.fdalawblog.net/files/mem.-op.-the-coalition-for-common-sense-.-.-.-v.-u.s.-08-cv-996-d.d.c.-nov.-30-209-2.pdf&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;span style="color:#ffffff;"&gt;*&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-5307360322866533711?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/5307360322866533711/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=5307360322866533711' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/5307360322866533711'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/5307360322866533711'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/surprise-tricare-ruling-handed-down.html' title='Surprise Tricare Ruling Handed Down'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-6140659936175851069</id><published>2009-12-16T08:30:00.007-05:00</published><updated>2009-12-16T09:11:55.779-05:00</updated><title type='text'>On the Fourth Day of CIS...</title><content type='html'>&lt;em&gt;As reported to Jess Ebert, Compliance Specialist&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;On the fourth day of CIS, the blog introduced to me...&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Compliance Manager Jon Dellaquila&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#ff0000;"&gt;(and Chris Didizian, Venessa Piper-Givler, and Amy VanDeCar&lt;/span&gt;)&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What’s your background?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: After graduating from Circle of Friends pre-school in the spring of 1985, I went on to receive my undergraduate degree in Physiology from the University of Maryland (I thought I wanted to go to med school). My career began in a large pharmaceutical company supporting the development and monitoring of a Phase I/II Pilot Plant as an analytical chemist in the quality control laboratory. After a few years, I moved into the world of clinical trials supporting several Phase I/II oncology studies from an in-house clinical research associate perspective. Prior to my current position, I spent some time working in quality monitoring and compliance overseeing in-house and clinical site trial management activities in various therapeutic areas. During this time I also received my master’s degree in Cell Biology and Biotechnology from the University of the Sciences in Philadelphia.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What projects and product lines do you work with at CIS?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I support CIS on the pharmaceutical side of the business in the clinical R&amp;amp;D and manufacturing arenas. Currently I am on-site at a client where I am responsible for assessing the risk benefit/analysis of R&amp;amp;D QA procedures and compliance related to the development of standard operating procedures (SOPs), policies and associated documents.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: Why did you decide to join CIS?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I decided to join CIS earlier this year to gain a different view of the pharmaceutical industry – from the outside looking in. Working for various departments within the industry allowed me to gain a strong understanding of the drug development life cycle from early stage R&amp;amp;D through to submission and approval. I always thought I wanted to get into pharmaceutical sales and found it difficult to break into that arena. When I interviewed with CIS, I saw the potential to wear many hats and also participate in various areas of the business. With that in mind, I thought it would be a perfect fit for me to leverage my career and educational experiences while also utilizing my social skills to create, establish and improve client relationships.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What’s your favorite holiday cookie?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: My Grandmom’s pizzelles - No one could make them like she could.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What’s your favorite holiday movie?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: My favorite holiday movie is National Lampoon’s Christmas Vacation. Christmas is not the same without a little Clark Griswald and cousin Eddie Johnson.&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;blockquote&gt;&lt;p&gt;&lt;a href="http://www.imdb.com/name/nm0001642/"&gt;&lt;span style="color:#ff0000;"&gt;Eddie&lt;/span&gt;&lt;/a&gt;&lt;a href="http://www.imdb.com/name/nm0001642/"&gt;&lt;span style="color:#ff0000;"&gt;:&lt;/span&gt; &lt;span style="color:#009900;"&gt;"&lt;/span&gt;&lt;span style="color:#009900;"&gt;You surprised to see us, Clark?"&lt;/span&gt;&lt;br /&gt;&lt;/a&gt;&lt;a href="http://www.imdb.com/name/nm0000331/"&gt;&lt;span style="color:#ff0000;"&gt;Clark&lt;/span&gt;&lt;/a&gt;&lt;a href="http://www.imdb.com/name/nm0001642/"&gt;&lt;span style="color:#ff0000;"&gt;:&lt;/span&gt; &lt;/span&gt;&lt;/a&gt;&lt;span style="color:#009900;"&gt;"Oh, Eddie... If I woke up tomorrow with my head sewn to the&lt;br /&gt;carpet, I wouldn't be more surprised than I am now.&lt;/span&gt;&lt;span style="color:#009900;"&gt;"&lt;/span&gt; &lt;/p&gt;&lt;/blockquote&gt;Email Jon any time at &lt;a href="mailto:jondellaquila@cis-partners.com"&gt;jondellaquila@cis-partners.com&lt;/a&gt;!&lt;br /&gt;&lt;br /&gt;Currently there are:&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;9 days until Christmas,&lt;/span&gt; &lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;10 days until Kwanzaa,&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#993399;"&gt;and 5 days until Winter Solstice!&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000099;"&gt;Tonight is the 6th night of Chanukah!&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-6140659936175851069?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/6140659936175851069/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=6140659936175851069' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/6140659936175851069'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/6140659936175851069'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/on-fourth-day-of-cis.html' title='On the Fourth Day of CIS...'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-6987278248786139503</id><published>2009-12-15T16:00:00.000-05:00</published><updated>2009-12-15T16:21:06.287-05:00</updated><title type='text'>Reminder- Monthly GP Forum tomorrow, December 16th!!!</title><content type='html'>Please join several of the subject matter experts from CIS tomorrow at &lt;strong&gt;10am&lt;/strong&gt; for an hour long discussion on GP hot topics.  The dial-in phone number is (888) 206-2266, and the pass-code is 1558717. &lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;em&gt;Topics for discussion include:&lt;/em&gt;&lt;/strong&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;Dave Rice will lead an update on the recent Tricare ruling.  CIS will recode the call for an iPod download. &lt;/li&gt;&lt;li&gt;Bill Baxter will give an update on the Advanced GP Forum venue at IIR in Baltimore in February.  &lt;/li&gt;&lt;li&gt;This is CIS’ 3rd year facilitating the full-day work shop, the agencies will be there to discuss topical issues in a “town hall” format.&lt;/li&gt;&lt;li&gt;Any other questions or topics that you would like to discuss! &lt;/li&gt;&lt;/ul&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-6987278248786139503?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/6987278248786139503/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=6987278248786139503' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/6987278248786139503'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/6987278248786139503'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/reminder-monthly-gp-forum-tomorrow.html' title='Reminder- Monthly GP Forum tomorrow, December 16th!!!'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-7109694356842861422</id><published>2009-12-15T09:30:00.004-05:00</published><updated>2009-12-16T08:47:58.760-05:00</updated><title type='text'>On the Third Day of CIS...</title><content type='html'>&lt;em&gt;As reported to Jess Ebert, CIS Compliance Specialist&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;On the third day of CIS, the blog introduced to me...&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Compliance Manager Chris Didizian&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;em&gt;(and SCM Venessa Piper-Givler, and SCM Amy VanDeCar)&lt;/em&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What’s your background?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I have a degree in Ancient History &amp;amp; Archaeology. Right out of college, I was looking to join a law firm and had a few prospects lined up until I was contacted by CIS. Impressed with what I saw, I joined within a month of the first interview and have since worked on a variety of projects with a focus on Sales &amp;amp; Marketing Activities.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What projects and product lines do you work with at CIS?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: For product lines, I manage the content on PCX Sales &amp;amp; Marketing. As for projects, I end up on roles relating to commercial compliance, specifically promotional review (MLR), PDMA, State Reporting, followed up by a lot of process work.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What do you like about CIS?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: Where to begin? Well the easiest way might be to break this response into two parts. The first pertains to my career. CIS presents many opportunities to work on a variety of projects for all pharma, large or small. With that said, each employee brings different perspectives and experiences thus establishing a versatile, learning environment. The second part to this answer pertains to more of a personal level. The people here are passionate, knowledgeable, and fun to be around. I’d like to specifically highlight passionate because it is contagious and allows for an enjoyable work environment.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What’s the best gift you ever gave someone for the holidays?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: One year I was convinced that I had the best gift for my fiancé. The idea took me a while to come up with and when it finally came to me, I was ecstatic. This gift was sure to be a shoe-in! It was a GPS Navigation System for her car. Good idea, right?! Maybe not…it didn’t sparkle.&lt;br /&gt;&lt;br /&gt;On Christmas Day she tore into the neatly wrapped gift (thank you Amazon for wrapping it – I still don’t know how) with a smile on her face as I sat watching giddy from the excitement. She looks at the picture on the box and with a very grim tone – smile replaced by a frown, asks, “What is it?” Please note I cleaned up her responses for our readers. After explaining the thought that went into it – trust me, the thought never counts when buying for a significant other – she made it clear, without even saying a word, that the next gift should sparkle. I guess that idea was a mistake, but we guys get at least one, right?&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What is your favorite holiday song?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I’m hoping nobody takes this the wrong way, but my favorite holiday song is “Grandma got run over by a reindeer.” I’ve often found myself driving around town volume raised, dancing, and singing to this loveable, countryesque classic. Sure, I’ve had a few close calls (driving and dancing are difficult for me!) and people may stare, laugh, or shout expletives (one time) but what’s not to love? Oh… and if you’re wondering… yes, I have it on my Ipod.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Email Chris any time at &lt;a href="mailto:chrisdidizian@cis-partners.com"&gt;chrisdidizian@cis-partners.com&lt;/a&gt;!&lt;br /&gt;&lt;br /&gt;Currently there are:&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;10 days until Christmas,&lt;/span&gt; &lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#009900;"&gt;11 days until Kwanzaa,&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#cc33cc;"&gt;and 6 days until Winter Solstice!&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000099;"&gt;Tonight is the 5th night of Chanukah!&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-7109694356842861422?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/7109694356842861422/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=7109694356842861422' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/7109694356842861422'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/7109694356842861422'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/on-third-day-of-cis.html' title='On the Third Day of CIS...'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-6716037956877948056</id><published>2009-12-14T09:30:00.003-05:00</published><updated>2009-12-16T08:48:29.839-05:00</updated><title type='text'>On the Second Day of CIS...</title><content type='html'>&lt;em&gt;As reported to Jess Ebert, CIS Compliance Specialist&lt;/em&gt;&lt;br /&gt;&lt;em&gt;&lt;/em&gt;&lt;br /&gt;&lt;em&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;On the second day of CIS, the blog introduced to me...&lt;/span&gt;&lt;/strong&gt;&lt;/em&gt;&lt;br /&gt;&lt;em&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Senior Compliance Manager Venessa Piper-Givler&lt;/span&gt;&lt;/strong&gt;&lt;/em&gt;&lt;br /&gt;&lt;em&gt;&lt;span style="color:#ff0000;"&gt;(and SCM Amy VanDeCar)&lt;/span&gt;&lt;/em&gt;&lt;br /&gt;&lt;em&gt;&lt;/em&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What's your background?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I have spent the majority of my career in GMP manufacturing specifically in final dosage, Active Pharmaceutical Ingredients, Sterile final and bulk as well as biologics. I started out in Quality Control as a bench chemist and microbiologist and then became a Supervisor of a QC laboratory. From there I moved into Quality Assurance and became a QA Manager and then a Director of Quality with QC, QA and Regulatory reporting into my organization. I hold a BS in Biochemistry and a Master's in Microbiology.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What projects and product lines do you work with at CIS?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I work in the area of GMP Manufacturing specifically in Quality/Regulatory. I work with Quality and Regulatory clients to set up quality systems, metrics, evaluate and harmonization procedures, perform internal and external audits and establish regulatory filings.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What do you like about CIS?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: As a consultant for CIS I am given the opportunity to use my skills in many areas of Quality and Regulatory. CIS also allows me to work with many clients to help them with their compliance with the regulatory guidances as well as their own internal standards. This opportunity has also allowed me to use and enhance my business skills to develop a strong manufacturing program.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What's your favorite holiday tradition?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: A Traditional Italian Christmas Eve Dinner!&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Q: What are you most thankful for this holiday season?&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I'm most thankful for my children, family and friends.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What is your favorite holiday song?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: My favorite song is Last Christmas.&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;/span&gt;&lt;br /&gt;Email Venessa any time at &lt;a href="mailto:vanessapiper-givler@cis-partners.com"&gt;vanessapiper-givler@cis-partners.com&lt;/a&gt;!&lt;br /&gt;&lt;br /&gt;There are currently:&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;11 days until Christmas,&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;12 days until Kwanzaa,&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#cc33cc;"&gt;and 7 days until Winter Solstice!&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#000099;"&gt;Tonight is the 4th night of Chanukah!&lt;/span&gt;&lt;/strong&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-6716037956877948056?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/6716037956877948056/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=6716037956877948056' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/6716037956877948056'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/6716037956877948056'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/on-second-day-of-cis.html' title='On the Second Day of CIS...'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-4613214075192905172</id><published>2009-12-11T11:00:00.000-05:00</published><updated>2009-12-11T11:29:03.200-05:00</updated><title type='text'>Articles of the Week!</title><content type='html'>Courtesy of: Scott Hoffman, CIS Senior Associate&lt;br /&gt;&lt;a href="mailto:scotthoffman@cis-partners.com"&gt;scotthoffman@cis-partners.com&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;1) House, Senate health care bills grow further apart&lt;br /&gt;&lt;a href="http://www.cnn.com/2009/POLITICS/12/09/health.care.differences/index.html"&gt;http://www.cnn.com/2009/POLITICS/12/09/health.care.differences/index.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;2) Democrats Feud Over Drug Imports Amendment in Health Care Bill&lt;br /&gt;&lt;a href="http://www.foxnews.com/politics/2009/12/10/democrats-feud-drug-imports-amendment-health-care/"&gt;http://www.foxnews.com/politics/2009/12/10/democrats-feud-drug-imports-amendment-health-care/&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;3) SEC probes four Pharmas for insider trading&lt;br /&gt;&lt;a href="http://www.fiercepharma.com/story/sec-probes-four-pharmas-insider-trading/2009-12-10"&gt;http://www.fiercepharma.com/story/sec-probes-four-pharmas-insider-trading/2009-12-10&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;4) Microsoft To Acquire Healthcare Specialist &lt;a href="http://www.informationweek.com/news/infrastructure/management/showArticle.jhtml?articleID=222001574"&gt;http://www.informationweek.com/news/infrastructure/management/showArticle.jhtml?articleID=222001574&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;5) GAO: FDA yet to make safety changes post-Vioxx&lt;br /&gt;&lt;a href="http://news.yahoo.com/s/ap/20091209/ap_on_he_me/us_fda_drug_safety"&gt;http://news.yahoo.com/s/ap/20091209/ap_on_he_me/us_fda_drug_safety&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;6) Primary care shortages hitting communities hard&lt;br /&gt;&lt;a href="http://www.cnn.com/2009/POLITICS/12/10/king.sotu.doctors/index.html"&gt;http://www.cnn.com/2009/POLITICS/12/10/king.sotu.doctors/index.html&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;7) Another Medical School Reports Doctors’ Industry Ties&lt;br /&gt;&lt;a href="http://blogs.wsj.com/health/2009/12/09/another-medical-school-reports-doctors-industry-ties/"&gt;http://blogs.wsj.com/health/2009/12/09/another-medical-school-reports-doctors-industry-ties/&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-4613214075192905172?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/4613214075192905172/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=4613214075192905172' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/4613214075192905172'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/4613214075192905172'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/articles-of-week_11.html' title='Articles of the Week!'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-2393558979215066232</id><published>2009-12-10T10:00:00.003-05:00</published><updated>2009-12-16T08:48:56.359-05:00</updated><title type='text'>On the First Day of CIS...</title><content type='html'>&lt;em&gt;Dear Readers,&lt;/em&gt;&lt;br /&gt;&lt;em&gt;&lt;/em&gt;&lt;br /&gt;&lt;em&gt;It’s that time of the year again when we take the opportunity to introduce to you some of our talented employees who have made CIS an industry-leading provider of pharmaceutical compliance services. &lt;/em&gt;&lt;br /&gt;&lt;em&gt;&lt;/em&gt;&lt;br /&gt;&lt;em&gt;For those of you who know us, you may just learn a thing or two about who we are and what makes us tick. For those of you who have not had the great pleasure of meeting us, we hope you like what you read!&lt;/em&gt;&lt;br /&gt;&lt;em&gt;&lt;/em&gt;&lt;br /&gt;&lt;em&gt;Thanks, and Happy Holidays!&lt;/em&gt;&lt;br /&gt;&lt;em&gt;Dana Zelig and Jess Ebert, CIS Compliance Specialists and PCB Co-Editors&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;On the first day of CIS, the blog introduced to me...&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="color:#ff0000;"&gt;Senior Compliance Manager Amy VanDeCar&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What's your background?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I have a degree in criminal justice and am working on an MBA. I got my start in pharma as a membership coordinator at a mid-sized manufacturer. I've worked in industry with chargebacks, contracts, analysis, and government pricing. After leaving industry, I spent a couple of years helping manufacturers implement and more extensively use commercial contracting and government pricing systems.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What projects and product lines do you work with at CIS?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I am a Director in CIS' Commercial Compliance practice. In this role, I work with manufacturers on commercial and government programs audits and assessments, ongoing calculations and recalculations, and other projects intended to increase their level of compliance.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What do you like about CIS?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: I enjoy the variety of projects I am able to work on at CIS.&lt;br /&gt;&lt;/span&gt;&lt;span style="color:#ff0000;"&gt;&lt;br /&gt;&lt;strong&gt;Q: Why did you decide to join CIS?&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;span style="color:#009900;"&gt;A: I joined CIS because of the company's unwavering commitment to compliance. I was drawn to the opportunity to work for a company that proactively informs customers about new and pending regulations and works with them to ensure a successful response.&lt;/span&gt;&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;Q: What are you looking forward to this holiday season?&lt;/span&gt;&lt;br /&gt;&lt;/strong&gt;&lt;span style="color:#009900;"&gt;A: The opportunity to slow down a bit, to take the time to enjoy family and friends.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;&lt;strong&gt;Q: What is your favorite holiday song?&lt;/strong&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;A: My favorite song is Silent Night.&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;&lt;/span&gt;&lt;br /&gt;Email Amy any time at &lt;a href="mailto:amyvandecar@cis-partners.com"&gt;amyvandecar@cis-partners.com&lt;/a&gt;!&lt;br /&gt;&lt;br /&gt;There are currently:&lt;br /&gt;&lt;span style="color:#ff0000;"&gt;16 days until Christmas,&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#000099;"&gt;2 days until Chanukah,&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#009900;"&gt;17 days until Kwanzaa, and&lt;/span&gt;&lt;br /&gt;&lt;span style="color:#cc33cc;"&gt;12 days until Winter Solstice!&lt;/span&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-2393558979215066232?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/2393558979215066232/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=2393558979215066232' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/2393558979215066232'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/2393558979215066232'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/on-first-day-of-cis.html' title='On the First Day of CIS...'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-6649389847929977790</id><published>2009-12-09T11:30:00.002-05:00</published><updated>2009-12-09T11:42:07.501-05:00</updated><title type='text'>CIS and Wrinkled Shirts</title><content type='html'>By: Steven Moore, CIS Director of Business Development&lt;br /&gt;&lt;a href="mailto:stevenmoore@cis-partners.com"&gt;stevenmoore@cis-partners.com&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;I do a lot of traveling by myself and that means I get to do a lot of thinking to myself.  Allow myself to introduce myself.  Welcome to the department of redundancy department…&lt;br /&gt;&lt;br /&gt;Nice, opening Steven.  (I had thought about starting over, but this is actually what I typed, so I’m sticking with it.)&lt;br /&gt;&lt;br /&gt;I’m not sure if you’ve heard about this whole Tiger Woods saga or not (for those of you who are reading this from Timbuktu --- which is for Dave Rice), but it really had got me to doing some real thinking.  I was perplexed with how someone who is/was married to a model, who possesses more talent than anyone I’d ever seen at his craft, who is the first BILLION dollar athlete and has all the things money can buy could be so insecure and unhappy.  &lt;br /&gt;&lt;br /&gt;I rather like the saying, “The older I get, the smarter my parents get.”  Because when I asked those questions to myself, the answer smacked me in the face (thanks Mom &amp;amp; Dad).  Because money simply can’t buy happiness!  Tiger can hit a golf ball 340 yards in the air.  I love my wife so much that what he’s done to his wife Elin is impossible to fathom in my head.  I’m happy. &lt;br /&gt;&lt;br /&gt;I do feel for him and his family --- especially his wife and children --- and I hope that he can learn from his mistakes and become a better man.  Heck, in reality, I feel like he needs to become a man first before he can become a better man.  But my sincere best wishes.&lt;br /&gt;&lt;br /&gt;So how does Tiger Woods relate to the Pharma Compliance Blog?  Good question.  I’ve been doing a lot of talking with Chris Cobourn, our VP of Consulting/GP/Calamari, etc., and we’ve talked a lot about how our people are ‘real’.  That there is seemingly an important distinction between the folks at CIS and many of the places and organizations that we’ve seen.  Now, he has seen a lot more places because I’m a spritely 30 and he’s, well, he’s tried a lot of different types of calamari --- but we both arrived at the same place having spent many a day on the road together.  And, to tie things back to Tiger Woods, he’s been a fake for years now!  But it’s one thing to think it of yourself and altogether different for someone else to say it to you. &lt;br /&gt;&lt;br /&gt;I was recently in a meeting with a current client --- one whom I have a tremendous amount of respect for --- and was told, &lt;em&gt;“I want you to know that we went with CIS because you’re real people that we can relate to.  Sure, you work hard and you do strong work, but it was the fact that you were real that made us go with you.”&lt;/em&gt;&lt;br /&gt;&lt;br /&gt;Pinch me.  If I wasn’t such a tough guy (yeah right), I might have shed a tear.  Seriously though, this was it!  This was what we’d been trying to accomplish years ago!  I also had another client tell us that a competitor rolled up in a shiny giant SUV and Armani suits --- and here I’m thinking, “Man, I wonder if I still know how to tie a tie…?”&lt;br /&gt;&lt;br /&gt;When I came to CIS, my responsibility was marketing and marketing alone.  I had met with the likes of Jim Collins, Toni Barsh, Chris Cobourn, Clarissa Crain and Chrissy Spicer and it was astonishing how real these people were.  Having come from a large company filled with politics and back-stabbing, I was overwhelmed in a good way.  These were the kinds of folks that you could see grabbing a pizza working till 1AM to finish a COT deliverable (for you, Clarissa) --- just as easily as you could see having a cold beer with them after a really long day.   I then realized that my job was to let the Pharma Compliance world know and then, subsequently, see it.  Most companies would be aghast at the notion of a PCXTini --- a neon blue martini named for our PCX product --- to launch our product at a conference.  But guess what?  A martini after 8 hours of GP talk at a conference is real! &lt;br /&gt;&lt;br /&gt;Since those days, I’ve moved on to do some consulting projects and then into business development --- but have passed the marketing gig to the far more capable than me hands of Karen Brown and Jackie O’Connor.  People loved our GP Geek T-shirts and many clients have told me they wear them out --- even to the gym!  People loved that we used drink stirrers that lit up and were used in our CalcTinis, used for our CalcPartner product --- which if you haven’t seen or learned about yet, you must! (selling OFF)  I had one client tell me that she keeps it in her purse and uses it at the bar!  Now that is some serious word of mouth advertising.  Not that every club and bar is crawling with GP and Compliance Geeks but as the NY Lotto says, “Hey, you never know…”&lt;br /&gt;&lt;br /&gt;Karen, our aforementioned Sr. Director of Marketing, once asked of the CIS team the following brilliant, angled question:  If CIS were a piece of furniture, what would it be and why? &lt;br /&gt;&lt;br /&gt;At first I was confused --- but her tact was bright and she knew what she was doing.  This is my exact response from an email sent back to her (I’m an email packrat --- my apologies to our server):&lt;br /&gt;&lt;br /&gt;&lt;blockquote&gt;&lt;em&gt;“If CIS were a piece of furniture, it would be a well-constructed, reliable&lt;br /&gt;desk.  To me, this imagery represents roll-up-your-sleeves hard work and&lt;br /&gt;dedication and that’s what we’re about now --- and hopefully well into the&lt;br /&gt;future!”&lt;/em&gt;&lt;/blockquote&gt;&lt;br /&gt;This isn’t supposed to be a piece that ‘toots our own horn’, but we do hope you agree.  We have and will make mistakes, but we will be the first to raise our hands, admit it and make it right no matter what it takes.  In the end, we hope you see that we’re real and we’ll work our butts off for you --- and if we ever waver from this, please do let us know.  We many not wear Armani suits everywhere we go, but our shirts will be pressed…&lt;br /&gt;&lt;br /&gt;However, more importantly, we won’t be afraid to get them wrinkled by rolling up our sleeves to finish your important deliverable ahead of time so you can present to management on a tight timeline --- or get you a proposal quickly because the fits about to hit the shan and you need our help. &lt;br /&gt;&lt;br /&gt;I know the folks here at CIS, and that’s something real that you can count on. &lt;br /&gt;&lt;br /&gt;For Your Space,&lt;br /&gt;&lt;br /&gt;Steven.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-6649389847929977790?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/6649389847929977790/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=6649389847929977790' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/6649389847929977790'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/6649389847929977790'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/cis-and-wrinkled-shirts.html' title='CIS and Wrinkled Shirts'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-868458207806864610.post-8168424997426896514</id><published>2009-12-04T09:00:00.001-05:00</published><updated>2009-12-04T09:00:07.501-05:00</updated><title type='text'>Articles of the Week!</title><content type='html'>Courtesy of: Jess Ebert, CIS Compliance Associate&lt;br /&gt;&lt;a href="mailto:jessicaebert@cis-partners.com"&gt;jessicaebert@cis-partners.com&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;1) Hawaii Opting Out Of Health Care Overhaul&lt;br /&gt;&lt;a href="http://www.npr.org/templates/story/story.php?storyId=120896275&amp;amp;ps=cprs"&gt;http://www.npr.org/templates/story/story.php?storyId=120896275&amp;amp;ps=cprs&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;2) Costs and Consequences of Direct-to-Consumer Advertising for Clopidogrel in Medicaid&lt;br /&gt;&lt;a href="http://archinte.ama-assn.org/cgi/content/short/169/21/1969?home"&gt;http://archinte.ama-assn.org/cgi/content/short/169/21/1969?home&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;3) The Uproar Over Mammography&lt;br /&gt;&lt;a href="http://economix.blogs.nytimes.com/2009/11/20/the-uproar-over-mammography/"&gt;http://economix.blogs.nytimes.com/2009/11/20/the-uproar-over-mammography/&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;4) Health Care Rationing, American-Style&lt;br /&gt;&lt;a href="http://economix.blogs.nytimes.com/2009/11/27/health-care-rationing-american-style/"&gt;http://economix.blogs.nytimes.com/2009/11/27/health-care-rationing-american-style/&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;5) Bureau of Labor Statistics' Health Care Charts:&lt;br /&gt;&lt;a href="http://www.bls.gov/spotlight/2009/health_care/"&gt;http://www.bls.gov/spotlight/2009/health_care/&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/868458207806864610-8168424997426896514?l=pharmacomplianceblog.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmacomplianceblog.blogspot.com/feeds/8168424997426896514/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=868458207806864610&amp;postID=8168424997426896514' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/8168424997426896514'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/868458207806864610/posts/default/8168424997426896514'/><link rel='alternate' type='text/html' href='http://pharmacomplianceblog.blogspot.com/2009/12/articles-of-week.html' title='Articles of the Week!'/><author><name>CIS Moderator</name><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='08812890014653518401'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry></feed>